Healthcare Archives - Life Sciences Times

Boston Life Sciences Times Announces 2025 Vanguard Award Winners

November 14, 2025

Mursla Bio Partners with Global Pharmaceutical Company to Advance Biomarker-Guided Precision Medicine in MASH

November 13, 2025

Parabilis Medicines Earns FDA Fast Track Designation for FOG-001 to Treat Desmoid Tumors

November 12, 2025

THIS WEEK'S STORIES

Quality Means Business Secures $2 Million Seed Funding to Launch QualiVerse Regulatory Intelligence Platform

November 12, 2025

ByHeart Expands Voluntary Nationwide Recall of Infant Formula as Investigation Continues

November 11, 2025

Veranex Appoints Jose Pablo Morales, M.D., as Chief Medical Officer

November 11, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Healthcare

Pan-Mass Challenge Donates Record $78 Million to Dana-Farber Cancer Institute

Stigma, Not Condition, Is the Biggest Barrier for 1 in 3 People Living With Chronic Conditions, Convatec Study Finds

Boston IVF Chief Scientific Officer Denny Sakkas, PhD Receives Prestigious 2025 ASRM Distinguished Researcher Award for Lifetime Contributions to Fertility Research

Ipsen Launches Educational Initiative to Support Teens and Young Adults Moving From Pediatric to Adult Healthcare

Zelis Study Finds Employers and Consumers See AI, Price Transparency, and Digital Tools as Keys to Better Healthcare

Most Read

Boston Life Sciences Times Announces 2025 Vanguard Award Winners

Cognision Partners with Kynexis to Use COGNISION System in Phase 2 Trial of KYN-5356 for Schizophrenia

Sensus Healthcare Expands Role of President Michael Sardano to Chief Commercial Officer

Dexcom Reveals Global Diabetes Advocates for World Diabetes Day

EDITOR PICKS

Boston Life Sciences Times Announces 2025 Vanguard Award Winners

Mursla Bio Partners with Global Pharmaceutical Company to Advance Biomarker-Guided Precision Medicine in MASH

Parabilis Medicines Earns FDA Fast Track Designation for FOG-001 to Treat Desmoid Tumors

THIS WEEK'S STORIES

Quality Means Business Secures $2 Million Seed Funding to Launch QualiVerse Regulatory Intelligence Platform

ByHeart Expands Voluntary Nationwide Recall of Infant Formula as Investigation Continues

Veranex Appoints Jose Pablo Morales, M.D., as Chief Medical Officer

POPULAR CATEGORY

ABOUT US

FOLLOW US